These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36520232)

  • 21. Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases.
    Stremitzer S; Vermeulen P; Graver S; Kockx M; Dirix L; Yang D; Zhang W; Stift J; Wrba F; Gruenberger T; Lenz HJ; Scherer SJ
    Br J Cancer; 2020 May; 122(10):1518-1524. PubMed ID: 32205863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathological growth pattern evolution of tumor in VX2 liver cancer model.
    Kong B; Zhou J; Wang H; Li Y; Pan Y; Zhu H; Zhang Q; Fan Q; Wang X; Zhang G
    Pathol Res Pract; 2023 Apr; 244():154401. PubMed ID: 36905696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocytic infiltration surrounding liver metastases from colorectal cancer.
    Okano K; Maeba T; Moroguchi A; Ishimura K; Karasawa Y; Izuishi K; Goda F; Usuki H; Wakabayashi H; Maeta H
    J Surg Oncol; 2003 Jan; 82(1):28-33. PubMed ID: 12501166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.
    Nierop PM; Höppener DJ; Buisman FE; van der Stok EP; Galjart B; Balachandran VP; Jarnagin WR; Kingham TP; Shia J; Mauer M; Nordlinger B; Julié C; Groot Koerkamp B; Doukas M; Vermeulen PB; Grünhagen DJ; D'Angelica MI; Verhoef C
    J Pathol Clin Res; 2022 Jan; 8(1):48-64. PubMed ID: 34480530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer.
    Imazu Y; Matsuo Y; Hokuto D; Yasuda S; Yoshikawa T; Kamitani N; Yoshida C; Sasaki T; Sho M
    Langenbecks Arch Surg; 2023 Feb; 408(1):72. PubMed ID: 36720759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer.
    Hida AI; Watanabe T; Sagara Y; Kashiwaba M; Sagara Y; Aogi K; Ohi Y; Tanimoto A
    Breast Cancer Res Treat; 2019 Nov; 178(2):283-294. PubMed ID: 31402409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastases.
    Buisman FE; van der Stok EP; Galjart B; Vermeulen PB; Balachandran VP; Coebergh van den Braak RRJ; Creasy JM; Höppener DJ; Jarnagin WR; Kingham TP; Nierop PMH; Sadot E; Shia J; Groot Koerkamp B; Grünhagen DJ; D'Angelica M; Verhoef C
    Clin Exp Metastasis; 2020 Oct; 37(5):593-605. PubMed ID: 32691187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 31. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-to-Lymphocyte Ratio and Intratumoral CD45RO-Positive T Cells as Predictive Factors for Longer Survival of Patients with Colorectal Liver Metastasis after Hepatectomy.
    Hamada T; Ishizaki H; Haruyama Y; Hamada R; Yano K; Kondo K; Kataoka H; Nanashima A
    Tohoku J Exp Med; 2020 Aug; 251(4):303-311. PubMed ID: 32779620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of histopathological growth pattern in predicting 3-year progression free survival after operation in patients with liver metastasis of colorectal cancer].
    Zhang YL; He HJ; Cheng J; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):26-31. PubMed ID: 33396983
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
    Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
    Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics.
    Wei S; Gou X; Zhang Y; Cui J; Liu X; Hong N; Sheng W; Cheng J; Wang Y
    Clin Exp Metastasis; 2024 Apr; 41(2):143-154. PubMed ID: 38416301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of Foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
    Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
    BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases.
    Leduc S; De Schepper M; Richard F; Maetens M; Pabba A; Borremans K; Jaekers J; Latacz E; Zels G; Bohlok A; Van Baelen K; Nguyen HL; Geukens T; Dirix L; Larsimont D; Vankerckhove S; Santos E; Oliveira RC; Dede K; Kulka J; Borbala S; Salamon F; Madaras L; Marcell Szasz A; Lucidi V; Meyer Y; Topal B; Verhoef C; Engstrand J; Moro CF; Gerling M; Bachir I; Biganzoli E; Donckier V; Floris G; Vermeulen P; Desmedt C
    NPJ Breast Cancer; 2023 Dec; 9(1):100. PubMed ID: 38102162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.
    Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Aosasa S; Ueno H
    Virchows Arch; 2019 Sep; 475(3):341-348. PubMed ID: 31076902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat hepatic resection in patients with colorectal liver metastases.
    Lee H; Choi SH; Cho YB; Yun SH; Kim HC; Lee WY; Heo JS; Choi DW; Jung KU; Chun HK
    World J Gastroenterol; 2015 Feb; 21(7):2124-30. PubMed ID: 25717247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.